Back

Attributable risk proportion of uncontrolled low-density lipoprotein cholesterol in recurrent acute coronary syndromes

1 September 2019 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: How good/bad are we in treating lipids Cardiovascular Risk Assessment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Elias Martinez Rey-Ranal

University Miguel Hernandez, Elche (Spain)

6 More presentations in this session

Presentation thumbnail
Intensification of lipid lowering therapy before and after publication of the IMPROVE-IT trial: A temporal analysis from the SPUM-ACS cohort
Doctor B. Gencer (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Statin treatment in children with familial hypercholesterolemia in Scandinavia
Doctor K. Svendsen (Oslo, NO)
Abstract Slides
Presentation thumbnail
Cost-effectiveness of evolocumab in patients with high atherosclerotic cardiovascular risk in Sweden
Doctor E. Hagstrom (Uppsala, SE)
Abstract Slides
Presentation thumbnail
Very low achieved low-density lipoprotein cholesterol level with alirocumab treatment after acute coronary syndrome: ODYSSEY OUTCOMES
Professor G. Schwartz (Aurora, US)
Abstract Slides
Presentation thumbnail
Remnant lipoprotein is a residual risk of future cardiovascular events in patients with stable coronary artery disease and on statin LDL-cholesterol levels less than 70 mg/dl
Doctor Y. Fujihara (Kofu, JP)
Abstract Slides

Access the full session

Session thumbnail
How good/bad are we in treating lipids

The Event

Event poster

ESC Congress 2019

1 September 2019 10:05 CET
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources